http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2007091501-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-655 |
filingDate | 2007-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2007091501-A1 |
titleOfInvention | Inflammatory bowel disease therapeutic agent or therapeutic method for inflammatory bowel disease comprising 2-amino-1,3-propanediol derivative as an active ingredient |
abstract | Chemical formula (1) 2-amino-1,3-propanediol derivative (specific example: 2-amino-2- [4- (3-benzyloxyphenylthio) -2-chlorophenyl]) which is a sphingosine-1-phosphate receptor agonist represented by Ethyl-1,3-propanediol hydrochloride), or pharmaceutically acceptable salts and hydrates thereof are inflammatory bowel disease Crohn's disease, colonic Crohn's disease, intestinal Behcet's disease, ulcerative colitis, hemorrhagic It was found useful as a therapeutic or prophylactic agent for rectal ulcer or ileal cystitis. |
priorityDate | 2006-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.